Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Total Debt (2016 - 2025)

Avanos Medical's Total Debt history spans 10 years, with the latest figure at $9.4 million for Q3 2024.

  • For Q3 2024, Total Debt rose 51.61% year-over-year to $9.4 million; the TTM value through Sep 2024 reached $9.4 million, up 51.61%, while the annual FY2023 figure was $8.6 million, 96.3% down from the prior year.
  • Total Debt for Q3 2024 was $9.4 million at Avanos Medical, down from $10.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $232.5 million in Q4 2022 and bottomed at $4.7 million in Q2 2022.
  • The 4-year median for Total Debt is $8.6 million (2023), against an average of $39.1 million.
  • The largest annual shift saw Total Debt surged 78.85% in 2022 before it plummeted 96.3% in 2023.
  • A 4-year view of Total Debt shows it stood at $130.0 million in 2021, then soared by 78.85% to $232.5 million in 2022, then tumbled by 96.3% to $8.6 million in 2023, then rose by 9.3% to $9.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Total Debt are $9.4 million (Q3 2024), $10.2 million (Q2 2024), and $9.4 million (Q1 2024).